A GAO report paints a picture of an already strained behavioral health system struggling to meet the treatment needs of millions of Americans with conditions like alcoholism and post-traumatic stress.
Emmarie Huetteman | Kaiser Health News
Posted inHealth
Four vital health issues — not tied to COVID — that Congress addressed in massive spending bill
Billions in pandemic relief from Congress got the attention, but bigger changes for health care were also in the legislation.
Posted inHealth
Warren and Klobuchar say they can lower drug prices without Congress’ help
Two Democrats running for president have promised to do — each by herself — what Washington has so far proven unable to do: lower the prices of prescription drugs.
Posted inHealth
The long road to lower drug prices hits some potholes
It’s July, and whether it’s the humidity or the lobbyists, Washington — and the prospects for substantial change on drug price-control legislation — look hazy. Two of the Trump administration’s primary targets, slashing rebates to drug supply middlemen and requiring prices in drug ads, fell apart in recent weeks.
Posted inHealth
Pelosi wants feds to negotiate drug prices — even for private insurers
As House Democrats hash out a proposal empowering the federal government’s top health official to negotiate lower drug prices, House Speaker Nancy Pelosi is taking it a step further and pushing a plan that could benefit even those Americans with private health insurance.
Posted inHealth
Trump administration rule would undo health care protections for LGBTQ patients
A new Trump administration proposal would change the civil rights rules dictating whether providers must care for patients who are transgender or have had an abortion. Supporters of the approach say it protects the freedom of conscience, but opponents say it encourages discrimination.
Posted inNews
Democrats taking key leadership jobs have pocketed millions from pharma
Three of the lawmakers who will lead the House next year as Congress focuses on skyrocketing drug costs are among the biggest recipients of campaign contributions from the pharmaceutical industry, a new KHN analysis shows.
Posted inNews
McCain’s complicated health-care legacy. He hated the ACA and also saved it.
There are many lawmakers who made their names in health care, seeking to usher through historic changes to a broken system.
John McCain was not one of them. And yet, the six-term senator from Arizona and decorated military veteran leaves behind his own health care legacy, seemingly driven less by his interest in health care policy than his disdain for bullies trampling the “little guy.”